These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36599125)
1. Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling. Gusev F; Gutkin E; Kurnikova MG; Isayev O J Chem Inf Model; 2023 Jan; 63(2):583-594. PubMed ID: 36599125 [No Abstract] [Full Text] [Related]
2. Computation of Absolute Binding Free Energies for Noncovalent Inhibitors with SARS-CoV-2 Main Protease. Ghahremanpour MM; Saar A; Tirado-Rives J; Jorgensen WL J Chem Inf Model; 2023 Aug; 63(16):5309-5318. PubMed ID: 37561001 [TBL] [Abstract][Full Text] [Related]
3. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. Cournia Z; Allen B; Sherman W J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive, Open-Source, and Automated Workflow for Multisite λ-Dynamics in Lead Optimization. Hu R; Zhang J; Kang Y; Wang Z; Pan P; Deng Y; Hsieh CY; Hou T J Chem Theory Comput; 2024 Feb; 20(3):1465-1478. PubMed ID: 38300792 [TBL] [Abstract][Full Text] [Related]
5. Automated, Accurate, and Scalable Relative Protein-Ligand Binding Free-Energy Calculations Using Lambda Dynamics. Raman EP; Paul TJ; Hayes RL; Brooks CL J Chem Theory Comput; 2020 Dec; 16(12):7895-7914. PubMed ID: 33201701 [TBL] [Abstract][Full Text] [Related]
6. Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A Stampelou M; Ladds G; Kolocouris A J Phys Chem B; 2024 Feb; 128(4):914-936. PubMed ID: 38236582 [TBL] [Abstract][Full Text] [Related]
7. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations. Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993 [TBL] [Abstract][Full Text] [Related]
8. Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro Ngo ST; Nguyen TH; Tung NT; Vu VV; Pham MQ; Mai BK Phys Chem Chem Phys; 2022 Dec; 24(48):29266-29278. PubMed ID: 36449268 [TBL] [Abstract][Full Text] [Related]
9. Relative Binding Free Energy Calculations Applied to Protein Homology Models. Cappel D; Hall ML; Lenselink EB; Beuming T; Qi J; Bradner J; Sherman W J Chem Inf Model; 2016 Dec; 56(12):2388-2400. PubMed ID: 28024402 [TBL] [Abstract][Full Text] [Related]
10. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease. Awoonor-Williams E; Abu-Saleh AAA Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090 [TBL] [Abstract][Full Text] [Related]
11. MDFit: automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics. Brueckner AC; Shields B; Kirubakaran P; Suponya A; Panda M; Posy SL; Johnson S; Lakkaraju SK J Comput Aided Mol Des; 2024 Jul; 38(1):24. PubMed ID: 39014286 [TBL] [Abstract][Full Text] [Related]
12. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases. Sivakumar D; Stein M Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582 [TBL] [Abstract][Full Text] [Related]
13. Free Energy Calculations for Protein-Ligand Binding Prediction. Jespers W; Åqvist J; Gutiérrez-de-Terán H Methods Mol Biol; 2021; 2266():203-226. PubMed ID: 33759129 [TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity. Weng YL; Naik SR; Dingelstad N; Lugo MR; Kalyaanamoorthy S; Ganesan A Sci Rep; 2021 Apr; 11(1):7429. PubMed ID: 33795718 [TBL] [Abstract][Full Text] [Related]
16. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay. Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646 [TBL] [Abstract][Full Text] [Related]
17. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953 [TBL] [Abstract][Full Text] [Related]
18. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Kavitha K; Sivakumar S; Ramesh B Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
20. Advances in Docking. Sulimov VB; Kutov DC; Sulimov AV Curr Med Chem; 2019; 26(42):7555-7580. PubMed ID: 30182836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]